Evidence map›Paper›PMID 29435680›Full record

ArticleClinical rheumatology2018

Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis : AIP associate with cIMT in AS.

Erkan Cure, Abdullah Icli, Ali Ugur Uslu, Davut Sakiz, Medine Cumhur Cure, Rabia Aydogan Baykara, Fatma Yavuz, Sevket Arslan, Adem Kucuk

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Pharmaceutical biology · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Erkan CureDepartment of Internal Medicine, Camlica Erdem Hospital, Istanbul, Turkey. erkancure@yahoo.com.ORCID http://orcid.org/0000-0001-7807-135X
Abdullah IcliDepartment of Cardiology, Necmettin Erbakan University, Konya, Turkey.
Ali Ugur UsluDepartment of Internal Medicine, Yunus Emre State Hospital, Eskisehir, Turkey.
Davut SakizDepartment of Endocrinology and Metabolism, Diskapi Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Medine Cumhur CureDepartment of Biochemistry, Istanbul Laboratory, Mecidiyekoy, Istanbul, Turkey.
Rabia Aydogan BaykaraDepartment of Physical Medicine and Rehabilitation, Malatya Training and Research Hospital, Malatya, Turkey.
Fatma YavuzDepartment of Internal Medicine, Dogubeyazit Doc. Dr. Yasar Eryilmaz State Hospital, Agri, Turkey.
Sevket ArslanDivision of Allergy and Clinical Immunology, Konya Training and Research Hospital, Konya, Turkey.
Adem KucukDivision of Rheumatology, Department of Internal Medicine, Necmettin Erbakan University, Konya, Turkey.
Necmettin Erbakan University · TRÇamlıca Erdem Hastahanesi · TRDiyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi · TREskişehir City Hospital · TRMalatya Devlet Hastanesi · TRMinistry of Health · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ankylosing spondylitis (AS) is associated with an increased risk of atherosclerotic cardiovascular disease (ACD). The atherogenic index of plasma (AIP), which is the logarithmic transformation of the plasma triglyceride (TG) level to the high-density lipoprotein level (HDL) ratio, has been suggested to be a novel marker in the identification of atherosclerosis risk. Therefore, this study aims to determine if the AIP can act as an accurate marker for the detection of subclinical atherosclerosis. Fifty-two male patients with AS and 52 age-, gender-, and body mass index (BMI)-matched healthy control subjects were included in the study. For each patient, AIP and total cholesterol (TC)/HDL values were calculated and carotid artery intima-media thickness (cIMT) was measured. The mean (SD) cIMT and median (range) AIP values for AS patients were higher than that of the healthy control subjects (0.60 ± 0.18 vs. 0.51 ± 0.10, p = 0.003 and 0.23 [- 0.32 to 0.85] vs. 0.09 [- 0.53 to 0.49], p = 0.007, respectively). A positive correlation was found between the patients' cIMT and AIP values (r = 0.307, p = 0.002) and TC/HDL values (r = 0.241, p = 0.014). Regression analysis revealed an independent association between the subclinical atherosclerosis and AIP (beta [β] = 0.309, p = 0.002). There were no independent correlations between subclinical atherosclerosis and TC (β = 0.245, p = 0.065), TG (β = 0.185, p = 0.515), HDL (β = 0.198, p = 0.231), TC/HDL (β = 0.032, p = 0.862), and low-density lipoprotein (LDL) (β = 0.151, p = 0.246). A strong and independent correlation exists between AIP and cIMT values. Therefore, the AIP could serve as a better marker than the TC/HDL ratio for the detection of subclinical atherosclerosis in AS patients.

Indexed as

AdultAtherosclerosisBiomarkersCarotid Intima-Media ThicknessCross-Sectional StudiesHumansLipoproteins, HDLMaleMiddle AgedSpondylitis, AnkylosingTriglyceridesBiomarkersLipoproteins, HDLTriglyceridesAnkylosing spondylitisAtherogenic index of plasmaCarotid intima-media thicknessSubclinical atherosclerosis

Identifiers

PMID29435680
OpenAlexW2788732882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.